Otsuka Pharmaceutical Co. Ltd.’s new alliance with US venture Click Therapeutics Inc. is aimed at developing and commercializing a novel prescription “digital therapeutic” for major depressive disorder, as part of the Japanese firm’s ongoing foray into digital health approaches and strategic focus on the mental health area.
The main goal is to provide an effective new tool to support the management of the highly debilitating condition, one...





